MRD Status Linked to Time to Next Treatment in MM
Cancer Therapy Advisor,
(HealthDay News) — Minimal residual disease (MRD) negativity is predictive of longer time to next treatment (TTNT) in patients…
(HealthDay News) — Minimal residual disease (MRD) negativity is predictive of longer time to next treatment (TTNT) in patients…
For patients with multiple myeloma (MM), minimal residual disease (MRD) negativity determined using next-generation sequencing (N…
News Professional By Elana Gotkine HealthDay Reporter WEDNESDAY, March 22, 2023 -- For patients with multiple myeloma (MM)…
WEDNESDAY, March 22, 2023 (HealthDay News) -- For patients with multiple myeloma (MM), minimal residual disease (MRD…